Cancer cells take advantage of these molecules on the platelet surface to form platelet–cancer cell conjugates through carbohydrate–protein recognition by P-selectin, protein bridging (e.g., by fibrinogen) between integrins as well as PECAM-1–integrin binding [268,269,270]. This evidence concerns the gene SELP and cancer.